Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5
- Resource Type
- Article
- Source
- The Journal of Allergy and Clinical Immunology: In Practice; September 2022, Vol. 10 Issue: 9 p2367-2374.e3
- Subject
- Language
- ISSN
- 22132198